Forbi Joseph C, Forbi Thanda D, Agwale Simon M
Clinical Virology Laboratory, Innovative Biotech, Keffi/Abuja, Nigeria.
J Infect Dev Ctries. 2010 Oct 28;4(10):662-7. doi: 10.3855/jidc.1015.
CD4+ T-cell levels are an important criterion for categorizing HIV-related clinical conditions. Late diagnosis of infection contributes to poor medical outcomes and the continuation of viral transmission. This population-based cohort study in north central Nigeria reports the initial CD4+ lymphocyte counts at the time of first HIV diagnosis and determines the approximate time interval when HIV infection was acquired.
Confirmed HIV-1 infected individuals (n = 588) for whom the dates of first HIV diagnosis were known were enrolled in this study. CD4+ lymphocyte counts were measured using a Fluorescence Activated Cell Sorter (FACS) platform that automatically quantifies CD4+ lymphocytes as absolute numbers of lymphocytes per µL of blood. The estimated time interval between HIV infection and time of first HIV diagnosis was determined as a function of the CD4+ lymphocytes' decay rate per calendar year.
The results showed that 22.1% and 49.7% of HIV-infected individuals present late with advanced (CD4+: 200-349 cells/mL) and severe (CD4+: < 200 cells/mL) immunosuppression respectively, while only 12.1% present with CD4+ ≥ 500 cells/mL and 16.2%with CD4+ between 350-499 cells/mL. Mean CD4+ counts for females were higher when compared to those of males (p > 0.05), The time interval between HIV infection and first diagnosis was approximately 6.1 years for males and 7.3 years for females.
The majority of HIV-infected individuals in this study accessed health care at late stages of infection, suggesting many HIV-infected individuals in Nigeria are unaware of their HIV status. More efficient programs for early diagnosis of HIV to prevent transmission are urgently required.
CD4+ T细胞水平是对HIV相关临床状况进行分类的重要标准。感染的延迟诊断会导致不良的医疗结果以及病毒传播的持续。这项在尼日利亚中北部开展的基于人群的队列研究报告了首次HIV诊断时的初始CD4+淋巴细胞计数,并确定了感染HIV的大致时间间隔。
本研究纳入了确诊的HIV-1感染者(n = 588),这些个体的首次HIV诊断日期已知。使用荧光激活细胞分选仪(FACS)平台测量CD4+淋巴细胞计数,该平台可自动将CD4+淋巴细胞定量为每微升血液中淋巴细胞的绝对数量。根据每年CD4+淋巴细胞的衰减率确定HIV感染与首次HIV诊断之间的估计时间间隔。
结果显示,分别有22.1%和49.7%的HIV感染者在感染晚期出现重度(CD4+:200 - 349个细胞/毫升)和严重(CD4+:< 200个细胞/毫升)免疫抑制,而只有12.1%的感染者CD4+≥500个细胞/毫升,16.2%的感染者CD4+在350 - 499个细胞/毫升之间。女性的平均CD4+计数高于男性(p > 0.05)。男性从HIV感染到首次诊断的时间间隔约为6.1年,女性为7.3年。
本研究中的大多数HIV感染者在感染晚期才获得医疗保健,这表明尼日利亚许多HIV感染者不知道自己的HIV感染状况。迫切需要更有效的早期HIV诊断项目以预防传播。